BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 24461312)

  • 1. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
    Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
    Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
    Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
    Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
    Tousen Y; Uehara M; Abe F; Kimira Y; Ishimi Y
    Nutr J; 2013 Sep; 12():127. PubMed ID: 24034304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional study of equol producer status and self-reported vasomotor symptoms.
    Newton KM; Reed SD; Uchiyama S; Qu C; Ueno T; Iwashita S; Gunderson G; Fuller S; Lampe JW
    Menopause; 2015 May; 22(5):489-95. PubMed ID: 25380274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of soy isoflavones in normal human breast tissue.
    Bolca S; Urpi-Sarda M; Blondeel P; Roche N; Vanhaecke L; Possemiers S; Al-Maharik N; Botting N; De Keukeleire D; Bracke M; Heyerick A; Manach C; Depypere H
    Am J Clin Nutr; 2010 Apr; 91(4):976-84. PubMed ID: 20164315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of whole soy and purified daidzein on ambulatory blood pressure and endothelial function--a 6-month double-blind, randomized controlled trial among Chinese postmenopausal women with prehypertension.
    Liu ZM; Ho SC; Chen YM; Tomlinson B; Ho S; To K; Woo J
    Eur J Clin Nutr; 2015 Oct; 69(10):1161-8. PubMed ID: 25782428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equol-producing status, isoflavone intake, and breast density in a sample of U.S. Chinese women.
    Tseng M; Byrne C; Kurzer MS; Fang CY
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1975-83. PubMed ID: 24019393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor-mediated effects of isoflavone supplementation were not observed in whole-genome gene expression profiles of peripheral blood mononuclear cells in postmenopausal, equol-producing women.
    van der Velpen V; Geelen A; Schouten EG; Hollman PC; Afman LA; van 't Veer P
    J Nutr; 2013 Jun; 143(6):774-80. PubMed ID: 23616509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production.
    Hall WL; Vafeiadou K; Hallund J; Bügel S; Koebnick C; Reimann M; Ferrari M; Branca F; Talbot D; Dadd T; Nilsson M; Dahlman-Wright K; Gustafsson JA; Minihane AM; Williams CM
    Am J Clin Nutr; 2005 Dec; 82(6):1260-8; quiz 1365-6. PubMed ID: 16332659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
    Liu ZM; Ho SC; Woo J; Chen YM; Wong C
    Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Legume, soy, tofu, and isoflavone intake and endometrial cancer risk in postmenopausal women in the multiethnic cohort study.
    Ollberding NJ; Lim U; Wilkens LR; Setiawan VW; Shvetsov YB; Henderson BE; Kolonel LN; Goodman MT
    J Natl Cancer Inst; 2012 Jan; 104(1):67-76. PubMed ID: 22158125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production.
    Hall WL; Vafeiadou K; Hallund J; Bugel S; Reimann M; Koebnick C; Zunft HJ; Ferrari M; Branca F; Dadd T; Talbot D; Powell J; Minihane AM; Cassidy A; Nilsson M; Dahlman-Wright K; Gustafsson JA; Williams CM
    Am J Clin Nutr; 2006 Mar; 83(3):592-600. PubMed ID: 16522905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women.
    Fuhrman BJ; Teter BE; Barba M; Byrne C; Cavalleri A; Grant BJ; Horvath PJ; Morelli D; Venturelli E; Muti PC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):33-42. PubMed ID: 18199709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women.
    Frankenfeld CL; McTiernan A; Aiello EJ; Thomas WK; LaCroix K; Schramm J; Schwartz SM; Holt VL; Lampe JW
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1156-62. PubMed ID: 15247126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dairy consumption is a significant correlate of urinary equol concentration in a representative sample of US adults.
    Frankenfeld CL
    Am J Clin Nutr; 2011 May; 93(5):1109-16. PubMed ID: 21389178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal cut-off value for equol-producing status in women: The Japan Nurses' Health Study urinary isoflavone concentration survey.
    Ideno Y; Hayashi K; Nakajima-Shimada J; Onizuka Y; Kishi M; Ueno T; Uchiyama S
    PLoS One; 2018; 13(7):e0201318. PubMed ID: 30048499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
    North American Menopause Society
    Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large inter-individual variation in isoflavone plasma concentration limits use of isoflavone intake data for risk assessment.
    van der Velpen V; Hollman PC; van Nielen M; Schouten EG; Mensink M; Van't Veer P; Geelen A
    Eur J Clin Nutr; 2014 Oct; 68(10):1141-7. PubMed ID: 24939433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.
    Frankenfeld CL; Atkinson C; Wähälä K; Lampe JW
    Eur J Clin Nutr; 2014 Apr; 68(4):526-30. PubMed ID: 24569543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women.
    Liu ZM; Ho SC; Chen YM; Ho S; To K; Tomlinson B; Woo J
    Mol Nutr Food Res; 2014 Apr; 58(4):709-17. PubMed ID: 24273218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.